Fundraising Fox
Melius Microbiomics
Vancouver, CA · Founded 2023 · 17 employees on LinkedIn · 1 known investors
Find your way into Melius Microbiomics
Sign up to see every warm intro you have to Melius Microbiomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Melius Microbiomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Melius MicroBiomics develops microbiome-based live biotherapeutics (its GEMM technology) to treat chronic inflammatory diseases, pursuing both human and animal health applications. The company's therapies originate from patented research at the University of British Columbia Okanagan's Gibson Lab.
Founders & leadership
Melius Microbiomics was founded in 2023 by Dr. Deanna Gibson, Robert Emlyn, Celinka Zhou, and Dr. Deanna L. Gibson, Ph.D..
DD
Dr. Deanna GibsonCo-Founder
RE
Robert EmlynCo-Founder & Chief Executive OfficerRobert Emlyn is a biotech entrepreneur who founded Innovate Phytotechnologies, a life sciences company focused on microbiome R&D and bioanalytical services, and previously led the development and sale of Innovate Clinical Centre. He is Co-Founder and CEO of Melius MicroBiomics, which develops microbiome-based live biotherapeutics to treat chronic inflammatory diseases.
DD
Dr. Deanna L. Gibson, Ph.D.Co-Founder & Non-Executive Chief Science Advisor
KH
Kevin HorganHead of Research & DevelopmentKevin Horgan is a physician-scientist with experience developing large and small molecule therapeutics across phases 1–4 in inflammation, immunology, CNS, and oncology at pharmaceutical and biotech companies. He holds expertise in microbiome science, AI applications, and diagnostics.
Investors · 1
Frequently asked questions
- What does Melius Microbiomics do?
- Melius MicroBiomics develops microbiome-based live biotherapeutics (its GEMM technology) to treat chronic inflammatory diseases, pursuing both human and animal health applications. The company's therapies originate from patented research at the University of British Columbia Okanagan's Gibson Lab.
- Who founded Melius Microbiomics?
- Melius Microbiomics was founded by Dr. Deanna Gibson, Robert Emlyn, Celinka Zhou, Dr. Deanna L. Gibson, Ph.D. in 2023.
- Who are Melius Microbiomics's investors?
- Melius Microbiomics's investors include Innovation UBC.
- Where is Melius Microbiomics headquartered?
- Melius Microbiomics is headquartered in Vancouver, CA.